Induced Apoptosis Investigation in Wild-type and FLT3-ITD Acute Myeloid Leukemia Cells by Nanochannel Electroporation and Single-cell qRT-PCR

Molecular Therapy : the Journal of the American Society of Gene Therapy
Keliang GaoLy James Lee

Abstract

Nanochannel electroporation (NEP) was applied to deliver precise dosages of myeloid cell leukemia-1 (Mcl-1)-specific siRNA and molecular beacons to two types of acute myeloid leukemia (AML) cells, FMS-like tyrosine kinase-3 wild-type (WT) and internal tandem duplications (ITD) type at the single-cell level. NEP, together with single-cell quantitative reverse transcription PCR, led to an observation showing nearly 20-folds more Mcl-1 siRNA than MCL1 mRNA were required to induce cell death for both cell lines and patient blasts, i.e., ~8,800 siRNAs for ~500 ± 50 mRNAs in ITD cells and ~6,000 siRNAs for ~300 ± 50 mRNAs in WT cells. A time-lapse study revealed that >75% MCL1 mRNA was downregulated within 1 hour after delivery of a small amount of siRNA. However, additional siRNA was required to inhibit the newly transcribed mRNA for >12 hours until the cell lost its ability of self-protection recovery. A multidelivery strategy of low doses and short delivery interval, which require 77% less siRNA and has the potential of lower side effects and clinical cost, was as effective as a single high-dose siRNA delivery. Our method provides a viable analytical tool to investigate gene silencing at the single-cell level for oligonucleotide-b...Continue Reading

References

Jun 26, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Stephen J BeebeKarl H Schoenbach
Aug 23, 2003·Science·Marjori Matzke, Antonius J M Matzke
Nov 25, 2003·Oncogene·Suzanne CoryJerry M Adams
May 27, 2004·Journal of the American Chemical Society·Gil Tae HwangByeang Hyean Kim
May 10, 2005·Science·Eric R Fearon, Ken M Cadigan
Nov 15, 2005·Proceedings of the National Academy of Sciences of the United States of America·Diana Y VargasSanjay Tyagi
Mar 15, 2006·Cell·Elissa P Lei, Victor G Corces
Nov 25, 2006·Science·Rich Jorgensen
Nov 8, 2008·Proceedings of the National Academy of Sciences of the United States of America·Hsiao-Yun YehWilfred Chen
Jan 10, 2009·Nature Biotechnology·John E Dick
Jan 16, 2009·Blood·Frank BreitenbuecherThomas Fischer
Sep 12, 2009·Science·Ines A DrinnenbergDavid P Bartel
Jul 12, 2011·Cancer Cell·P Leif Bergsagel, W Michael Kuehl
Aug 3, 2011·Proceedings of the National Academy of Sciences of the United States of America·Adam K WhiteCarl L Hansen
Sep 8, 2011·Cancer Research·Anja van de StolpeJaap M J den Toonder
Oct 18, 2011·Nature Nanotechnology·Pouyan E BoukanyL James Lee
Apr 12, 2012·Proceedings of the National Academy of Sciences of the United States of America·Ann-Kathrin EisfeldAlbert de la Chapelle
Jul 26, 2012·Blood Cancer Journal·S KasperT Fischer
Jan 1, 2013·Proceedings of the National Academy of Sciences of the United States of America·Qingfei JiangCatriona H M Jamieson

❮ Previous
Next ❯

Citations

Oct 4, 2016·Trends in Biotechnology·Tairong KuangDaniel Gallego-Perez
Oct 19, 2016·Lab on a Chip·Lingqian ChangLy James Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Journal of the National Cancer Institute
Weiguo ZhangMichael Andreeff
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
N Govedarovic, G Marjanovic
The Korean journal of laboratory medicine
Soon Hee ChangJang Soo Suh
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
Min RuanXiao-Fan Zhu
© 2022 Meta ULC. All rights reserved